Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Biotechnology
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early-to-late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology...
products include Actikerall, Epuris, Vaniqa and Natroba. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. Its Natroba (spinosad) Topical Suspension is indicated for the topical treatment of head lice and scabies infestations in adult and pediatric patients.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
(1)
•••
GJS471
X
Comment by
GJS471
on Feb 09, 2023 2:04pm
RE:RE:No release date yet for Q4 and Full yr 2022 results
My apologies, you are absolutely correct. I thought there was a date announcing the release of the YE for CPH last year but all I see is the actual release date. I look forward to
...more
(106)
•••
Northforce13
X
Comment by
Northforce13
on Feb 08, 2023 4:16pm
RE:No release date yet for Q4 and Full yr 2022 results
last year Q4 results were out March 17th. We are Feb 8th.
(1)
•••
GJS471
X
Post by
GJS471
on Feb 07, 2023 2:02pm
No release date yet for Q4 and Full yr 2022 results
Given the history of earnings releases, it makes me wonder if they are hoping to include some additional news about the company and are holding back the date to release the results until they can make
...more
(29)
•••
stockfy
X
Post by
stockfy
on Nov 14, 2022 5:16am
CPH: Outperformer, Give Credit When Credit Is Due
I just want to give credit where credit is due. I bought CPH thanks to Value Digger, a veteran fund manager and author from Seeking Alpha and his research. I m one of his subscribers. Value Digger
...more
(29)
•••
stockfy
X
Comment by
stockfy
on Nov 14, 2022 5:12am
RE:RE:Very good Q
Where are all those bears who were posting ugly comments against CPH and its management team about one year ago when CPH was below CAD$1?
(0)
•••
Rsoleblocka
X
Comment by
Rsoleblocka
on Nov 12, 2022 12:52am
RE:Very good Q
Nice synopsis, I almost sold today at 3.70 but could not pull the trigger. As longs as they do not buy something for the sake of doing so I am still comfortable with this holding. Cheers
(106)
•••
Northforce13
X
Post by
Northforce13
on Nov 11, 2022 1:28pm
Very good Q
Solid results, big boost in profitability, though a big chunk of which is attributable to tax revaluation. 1) Great profitability 2) Tax revaluation was encouraging, indicates less
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 10, 2022 6:30pm
New Press Release - Cipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by USD$1.09 in Cash Per Share
(All figures are presented in U.S. dollars)EPS increased YoY by $0.08 to $0.11 in the third quarter;Strengthened balance sheet and demonstrated continued positive cash flow, ending Q3 with $27.5 million in cash and Adjusted EBITDA2 increased 19% to $2.6 million; EBITDA2 increased 67% to $2.5...
read article.
(6)
•••
DrewJackson
X
Comment by
DrewJackson
on Nov 09, 2022 12:52pm
RE:Tomorrrow the wait will be over....
It's available on https://www.sedi.ca/ The System for Electronic Disclosure by Insiders (SEDI) is Canada's website for filing and viewing insider trades. SEDI is old and clunky, just
...more
(1)
•••
GJS471
X
Post by
GJS471
on Nov 09, 2022 8:59am
Tomorrrow the wait will be over....
Given the recent increase in the stock price, people are obviously thinking that they will report a solid quarter but it also looks like an expectation of M&A activity. Which was what people
...more
(6)
•••
DrewJackson
X
Comment by
DrewJackson
on Nov 03, 2022 1:39pm
RE:RE:Great read!
No, it's a SPAM link. Please report it as such (that's what I did). It has nothing to do with Cipher Pharmaceuticals. It's just a puff piece for Actinium Pharmaceuticals.
(0)
•••
Rsoleblocka
X
Comment by
Rsoleblocka
on Nov 02, 2022 10:30pm
RE:Great read!
Does this relate to cipher? Thanks
(26)
•••
BryceCanada
X
Post by
BryceCanada
on Nov 02, 2022 5:09pm
Great read!
https://trendingmarketnews.com/biotechs-next-generational-breakout/?utm_source=mcnalliemoney&utm_medium=influencer&utm_campaign=atnmz_us
(106)
•••
Northforce13
X
Post by
Northforce13
on Oct 09, 2022 12:43am
M&A Imminent
There was an overwhelming amount of talk and indications on the last conference call that a M&A deal was imminent, if not already in the works. If I recall, they changed CFOs, but kept the
...more
(106)
•••
Northforce13
X
Comment by
Northforce13
on Sep 01, 2022 6:20pm
RE:Ez small fast gain available @2.20
Out @2.60, 18% gain in 1 month on the small fun fun play in my tfsa No bearing on my primary position, which I've held for > 1 year and continue to hold and is >200 times as big in size
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Freegold Achieves over 90% Gold Recovery Using BIOX® and greater than 92% Gold Recovery using POX
Eminent Continues to Hit Gold Mineralization at its Hot Springs Range Project in Nevada
Maiden Resource Estimate of 54 Moz at 284 gpt Silver, Highlights High-Grade Potential at Columba